VG Life Sciences VG Life Sciences (VGLS, also known as SB Technology Holdings, formerly Viral Genetics) is a company that develops therapeutic and diagnostic pharmaceutical and medical products. | Oncolytics Biotech Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies. | |
Founding Date | Founding Date 1995 | Founding Date 1998 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations New York, US HQ | Locations Calgary, CA HQ Calgary, CA San Diego, US |
Employees | Employees 1 | Employees 28 |
Valuation ($) | Valuation ($) 2.1 m | Valuation ($) 93.9 m |
Financial | ||
Net income | Net income ($6.2m) (FY, 2014) | Net income ($28.8m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 2.8m | Total funding raised $ 24m |
Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies.
View company